Creative Medical Tech
(NASDAQ:CELZ)
$4.2588
-0.2089[-4.68%]
At close: May 29
$4.2588
0[0.00%]
After Hours: 4:45PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Creative Medical Tech Stock (NASDAQ:CELZ), Quotes and News Summary

Creative Medical Tech Stock (NASDAQ: CELZ) stock price, news, charts, stock research, profile.

Open$4.470
Close$4.350
Volume / Avg.2.843K / 204.828K
Day Range4.334 - 4.470
52 Wk Range3.930 - 10.281
Market Cap$5.741M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
44
Short Interest
1.34%
Days to Cover4.02

Recent News

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Avi Kapoor
Why Is Diabetes Focused Creative Medical Stock Surging On Thursday?
FDA approval under expanded access for Creative Medical. CELZ-201, a pioneering cell-based program, targets abnormal glucose tolerance to prevent Type 1 diabetes.
Vandana Singh
Sponsored
Creative Medical Technology Holdings (NASDAQ: CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem™ For Addressing Chronic Lower Back Pain
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company has received clearance from the FDA to conduct a phase 1/2 clinical trial using their innovative StemSpine® treatment known as AlloStem™.
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CELZ
VIRI

FAQ

Q

How do I buy Creative Medical Tech (CELZ) stock?

A

You can purchase shares of Creative Medical Tech (NASDAQ: CELZ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Creative Medical Tech's (CELZ) competitors?

A

Other companies in Creative Medical Tech’s space includes: Virios Therapeutics (NASDAQ:VIRI), Entero Therapeutics (NASDAQ:ENTO), Synaptogenix (NASDAQ:SNPX), NuCana (NASDAQ:NCNA) and Genprex (NASDAQ:GNPX).

Q

What is the target price for Creative Medical Tech (CELZ) stock?

A

The latest price target for Creative Medical Tech (NASDAQ: CELZ) was reported by Roth Capital on Friday, February 25, 2022. The analyst firm set a price target for 10.00 expecting CELZ to rise to within 12 months (a possible 134.81% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Creative Medical Tech (CELZ)?

A

The stock price for Creative Medical Tech (NASDAQ: CELZ) is $4.2588 last updated May 29, 2024 at 4:45 PM EDT.

Q

Does Creative Medical Tech (CELZ) pay a dividend?

A

There are no upcoming dividends for Creative Medical Tech.

Q

When is Creative Medical Tech (NASDAQ:CELZ) reporting earnings?

A

Creative Medical Tech’s Q2 earnings are confirmed for Friday, August 9, 2024.

Q

Is Creative Medical Tech (CELZ) going to split?

A

There is no upcoming split for Creative Medical Tech.

Q

What sector and industry does Creative Medical Tech (CELZ) operate in?

A

Creative Medical Tech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch